N-Butylglycidyl ether: the formation of a novel metabolite of an epoxide
Eadsforth, C.V.; Logan, C.J.; Page, J.A.; Regan, P.D.
Drug Metabolism and Disposition the Biological Fate of Chemicals 13(2): 263-264
1985
ISSN/ISBN: 0090-9556 PMID: 2859179 Document Number: 4889
n-Butylglycidyl ether (other names include butoxymethyl oxirane and 1-glycidyloxy-butane) is currently used as a major reactive diluent for industrial epoxy resin systems.
Document emailed within 1 workday
Related Documents
Slack, J.A.; Ford-Hutchinson, A.W. 1980: Determination of a urinary epoxide metabolite of alclofenac in man Drug Metabolism and Disposition: the Biological Fate of Chemicals 8(2): 84-86Costa, L.G.; Deng, H.; Gregotti, C.; Manzo, L.; Faustman, E.M.; Bergmark, E.; Calleman, C.J. 1992: Comparative studies on the neuro- and reproductive toxicity of acrylamide and its epoxide metabolite glycidamide in the rat Neurotoxicology 13(1): 219-224
Ginsberg, G.L.; Atherholt, T.B. 1990: DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxide after injection of benzo(a)pyrene or the diol-epoxide Cancer Research 50(4): 1189-1194
Wedlund, P.J.; Sweetman, B.J.; Wilkinson, G.R.; Branch, R.A. 1987: Pharmacogenetic association between the formation of 4-hydroxymephenytoin and a new metabolite of S-mephenytoin in man Drug Metabolism and Disposition: the Biological Fate of Chemicals 15(2): 277-279
Regdon, G.; Erös, I. 1984: Rheological testing of cellulose ether hydrogels. I. Factors influencing the formation of the structure and structural forces Acta Pharmaceutica Hungarica 54(3): 133-141
Schlossmann, K.; Pütter, J. 1973: Studies on the formation of the lactone and acid form of the main metabolite of mefruside Arzneimittel-Forschung 23(2): 255-262
Pietrabissa, A.; Di Stefano, R.; Collecchi, P.; Campanella, P.G.; Della Capanna, S.; Scarcello, E.; Turini, L.; Bevilacqua, G.; Mosca, F. 1994: Effect of cyclosporine-A pretreatment on lidocaine metabolite formation in the regenerating rat liver Transplantation Proceedings 26(5): 2908-2909
Sinz, R.; Wilfert, K. 1970: Effect of guaiacol glyceryl ether on the formation of conditioned reflexes, "EEG" arousal and spontaneous bioelectric activity of brain in rats Acta Biologica et Medica Germanica 24(6): 857-869
Grech-Bélanger, O.; Turgeon, J.; Lalande, M.; Bélanger, P.M. 1991: Meta-hydroxymexiletine, a new metabolite of mexiletine. Isolation, characterization, and species differences in its formation Drug Metabolism and Disposition: the Biological Fate of Chemicals 19(2): 458-461
Cummings, J.; Milroy, R. 1986: In vitro formation of a toxic aglycone metabolite of 4-demethoxydaunorubicin in conditions that parallel the stomach Anticancer Research 6(5): 1177-1179
Houston, J.B.; Cassidy, M.K. 1982: Rate limiting steps in metabolite kinetics: formation of 5-acetylaminosalicylate after administration of 5-aminosalicylate Journal of Pharmacy and Pharmacology 34(8): 536-538
Levine, M.; Bellward, G.D. 1995: Effect of cimetidine on hepatic cytochrome P450: evidence for formation of a metabolite-intermediate complex Drug Metabolism and Disposition: the Biological Fate of Chemicals 23(12): 1407-1411
Shaw, P.N.; Tseti, J.; Warburton, S.; Adedoyin, A.; Houston, J.B. 1986: Inhibition of antipyrine metabolite formation. Steady state studies with cimetidine and metyrapone in rats Drug Metabolism and Disposition: the Biological Fate of Chemicals 14(2): 271-276
Kahl, R.; Friederici, D.E.; Kahl, G.F.; Ritter, W.; Krebs, R. 1980: Clotrimazole as an inhibitor of benzo[a]pyrene metabolite-DNA adduct formation in vitro and of microsomal mono-oxygenase activity Drug Metabolism and Disposition: the Biological Fate of Chemicals 8(4): 191-196
Teunissen, M.W.; De Leede, L.G.; Boeijinga, J.K.; Breimer, D.D. 1985: Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state Journal of Pharmacology and Experimental Therapeutics 233(3): 770-775
Ding, J-Jie.; Jiao, Z.; Yu, Y-Qiu.; Shi, X-Jin. 2007: Development and identifiability analysis of parent-metabolite pharmacokinetic model for risperidone and its main active metabolite 9-hydroxyrisperidone Yao Xue Xue Bao 42(6): 631-638
Oesch, F. 1983: Drug detoxification: epoxide hydrolase Progress in Clinical and Biological Research 135: 81-105
Mukendi, N.; de Meester, C.; Rollman, B. 1995: In vitro study of the metabolic conversion of aflatoxin B1 into its epoxide Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 189(4): 643-656
Kahl, R.; Wulff, U. 1979: Induction of rat hepatic epoxide hydratase by dietary antioxidants Toxicology and Applied Pharmacology 47(2): 217-227
Lee, S.H.; Goldberg, I.H. 1988: Role of epoxide in neocarzinostatin chromophore stability and action Molecular Pharmacology 33(4): 396-401